Linked Data API
Show Search Form
Search Results
 |
human indexable |  |
 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
published | |
|
||||||||
|
registered interest |  |
|
||||||||
|
answer date |   |
|||||||||
|
date | |
|||||||||
|
date tabled | |
|||||||||
|
ddp created | |
|||||||||
|
answering body |
|
|||||||||
|
question status | Tabled | |
||||||||
|
answering dept id | 17 | |
||||||||
 |
answering dept short name | Health and Social Care | |
||||||||
|
answering dept sort name | Health and Social Care | |
||||||||
|
ddp modified |
|
|||||||||
|
hansard heading | NHS: Drugs | |
||||||||
|
house id | 1 | |
||||||||
|
identifier | 62793 | |
||||||||
|
legislature |
|
|||||||||
|
parliament number | 58 | |
||||||||
|
question first answered |
|
|||||||||
|
question text | To ask the Secretary of State for Health and Social Care, if she will make a comparative estimate of the annual savings that (a) unbranded generic, (b) branded generic and (c) biosimilar medicines have contributed to the NHS drug bill compared to branded prices had those medicines not been available for each year since 2012 for which data is available. | |
||||||||
|
session |
|
|||||||||
|
session number | 3 | |
||||||||
|
tabling member constituency | Harlow | |
||||||||
|
tabling member printed |
|
|||||||||
|
title | House of Commons Tabled Parliamentary Question 2022/23 62793 |  |
||||||||
|
type |
|
|||||||||
|
uin | 62793 | |
||||||||
|
version | 1 | |
||||||||
|
written parliamentary question type | Ordinary | |
||||||||
|
answer | answer | |||||||||
|
creator |
|
|||||||||
|
publisher | 25259 | |||||||||
|
tabling member |
|
|||||||||
